Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2

References

• Huang J, Cao Y, Du J, Bu X, Ma R, Wu C. Printing with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses. Vaccine. 2007;25:6981–91. doi:10.1016/j.vaccine.2007.06.047.
   PubMed Web of Science ®Google Scholar
• Kam YW, Kien F, Roberts A, Cheung YC, Lamirande EW, Vogel L, Chu SL, Tse J, Guarner J, Zaki SR, et al. Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro. Vaccine. 2007;25:729–40.
   PubMed Web of Science ®Google Scholar
• Chu Y-K, Ali GD, Jia F, Li Q, Kelvin D, Couch RC, Harrod KS, Hutt JA, Cameron C, Weiss SR, et al. The SARS-CoV ferret model in an infection-challenge study. Virology. 2008;374:151–63.
   PubMed Web of Science ®Google Scholar
• Masters PS, Perlman S. Coronaviridae in field,s virology. In: Knipe DM, Howley PM editors. Lippincott. Vol. 1. Philadelphia (USA): Williams & Wilkins; 2013. p. 825–58.
   Google Scholar
• Kumaki Y, Wandersee MK, Smith AJ, Zhou Y, Simmons G, Nelson NM, Bailey KW, Vest ZG, Li J-K-K, Chan PK-S, et al. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antiviral Res. 2011;90:22–32. doi:10.1016/j.antiviral.2011.02.003.
   PubMed Web of Science ®Google Scholar
• Bermingham A, Chand MA, Brown CS, Aarons E, Tong C, Langrish C, Zambon M. Severe respiratory illness caused by a novel coronavirus, in a patient transderred to the United Kingdom from the Middle East, September 2012. Euro Surveill. 2012;17:20290.
   PubMedGoogle Scholar
• Karypidou K, Ribone SR, Quevedo MA, Persoons L, Pannecouque C, Helsen C, Claessens F, Dehaen W. Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents. Bioorg Med Chem Lett. 2018;28:3472–76. doi:10.1016/j.bmcl.2018.09.019.
   PubMed Web of Science ®Google Scholar
• Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev. 2020. http://doi.10.1016/j,tmrv.2020.02.003.
   PubMed Web of Science ®Google Scholar
• Akerstrom S, Gunalan V, Tat Keng C, Tan Y-J, Mirazimi A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology. 2009;395:1–9. doi:10.1016/j.virol.2009.09.007.
   PubMed Web of Science ®Google Scholar
• Adams MJ, Carstens EB. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012). Arch Viral. 2012;157:1411–22. doi:10.1007/s00705-012-1299-6.
   PubMed Web of Science ®Google Scholar
• Sims AC, Burkett SE, Yount B, Pickles RJ. SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium. Virus Res. 2008;133:33–44. doi:10.1016/j.virusres.2007.03.013.
   PubMed Web of Science ®Google Scholar
• Lu G, Wang Q, Gao GF. Bat-to-human: spike features determining host jump of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trend Microbiol. 2015;23(8):468–78. doi:10.1016/j.tim.2015.06.003.
   PubMed Web of Science ®Google Scholar
• Ar Gouilh M, Puechmaille SJ, Diancourt L, Vandenbogaert M, Serra-Cobo J, Roig ML, Brown P, Moutou F, Caro V, Vabret A, et al. SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found in western old-world. Virology. 2018;517:88–97. doi:10.1016/j.virol.2018.01.014.
   PubMed Web of Science ®Google Scholar
• Coleman PM, Lawrence MC. The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol. 2003;4:309–19. doi:10.1038/nrm1076.
   PubMed Web of Science ®Google Scholar
• Chernomordik LV, Kozlov MM. Mechanics of membrane fusion. Nat. Struct. Mol Biol. 2008;15:675–83.
   Web of Science ®Google Scholar
• Harrison SC. Viral membrane fusion. Nat Struct Mol Biol. 2008;15:690–98. doi:10.1038/nsmb.1456.
   PubMed Web of Science ®Google Scholar
• White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol. 2008;43:189–219. doi:10.1080/10409230802058320.
   PubMed Web of Science ®Google Scholar
• White JM, Whittaker GR. Fusion of enveloped viruses in endosomes. Traffic. 2016;17:593–614. doi:10.1111/tra.12389.
   PubMed Web of Science ®Google Scholar
• Bosch BJ, van der Zee R, de Haan CAM, Rottier PJM. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77:8801–11.
   PubMed Web of Science ®Google Scholar
• Millet JK, Whittaker GR. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology. 2018;517:3–8.
   PubMed Web of Science ®Google Scholar
• Yu P, Hu B, Shi Z-L, Cui J. Geographical structure of bat SARS-related coronaviruses. Infect Genet Evol. 2019;69:224–29.
   PubMed Web of Science ®Google Scholar
• Gillissen A, Ruf BR. Severe acute respiratory syndrome (SARS). Med Klin. 2003;98:319–25.
   Google Scholar
• Zhong N-S, Wong GWK. Epidemiology of severe acute respiratory syndrome (SARS): adults and children. Paediatr Respir Rev. 2004;5:270–74.
   PubMedGoogle Scholar
• Chu KH, Tsang WK, Tang CS, Lam MF, Lai FM, To KF, Fung KS, Tang HL, Yan WW, Chan HWH, et al. Acute renal impairment in coronavirus-associated severe acute respiratory syndrome. Kidney Int. 2005;67:698–705.
   PubMed Web of Science ®Google Scholar
• Pillaiyar T, Manickam M, Namasivayam V, Hayashi Y, Jung S-H. An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J Med Chem. 2016;59:6595–628. doi:10.1021/acs.jmedchem.5b01461.
   PubMed Web of Science ®Google Scholar
• Zhai S, Liu W, Yan B. Recent patents on treatment of severe acute respiratory syndrome (SARS). Recent Pat Antiinfect Drug Discov. 2007;2:1–10.
   PubMedGoogle Scholar
• Hong X, Currier GW, Zhao X, Jiang Y, Zhou W, Wei J. Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year follow-up study. Gen Hosp Psychiatry. 2009;31:546–54.
   PubMed Web of Science ®Google Scholar
• Yam LY-C, Lau AC-W, Lai FY-L, Shung E, Chan J, Wong V. Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong. J Infect. 2007;54:28–39.
   PubMed Web of Science ®Google Scholar
• Zhang N, Tang J, Lu L, Jiang S, Du L. Receptor-binding domain-based subunit vaccines against MERS-CoV. Virus Res. 2015;202:151–59.
   PubMed Web of Science ®Google Scholar
• Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019;16:69.
   PubMed Web of Science ®Google Scholar
• Saminathan M, Chakraborty S, Tiwari R, Dhama K, Verma A. Coronavirus infection in equines: a review. Asian J Anim Vet Adv. 2014;9:164–76.
   Google Scholar
• Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, Poon LL, Guan Y, Rozanov M, Spaan WJ, Gorbalenya AE. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol. 2003;331:991–1004.
   PubMed Web of Science ®Google Scholar
• Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3(9):e343. doi:10.1371/journal.pmed.0030343.
   PubMed Web of Science ®Google Scholar
• Netland J, DeDiego ML, Zhao J, Fett C, Alvarez E, Nieto-Torres JL, Enjuanes L, Perlman S. Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease. Virology. 2010;399:120–28.
   PubMed Web of Science ®Google Scholar
• DeDiego ML, Alvarez E, Almazan F, Rejas MT, Lamirande E, Roberts A, Shieh WJ, Zaki SR, Subbarao K, Enjuanes L. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol. 2007;81:1701–13.
   PubMed Web of Science ®Google Scholar
• DeDiego ML, Pewe L, Alvarez E, Rejas MT, Perlman S, Enjuanes L. Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice. Virology. 2008;376:379–89.
   PubMed Web of Science ®Google Scholar
• Ohnishi K, Hattori Y, Kobayashi K, Akaji K. Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor. Bioorg Med Chem. 2019;27:425–35. doi:10.1016/j.bmc.2018.12.019.
   PubMed Web of Science ®Google Scholar
• Law PYP, Liu Y-M, Geng H, Kwan KH, Waye MM-Y, Ho -Y-Y. Expression and functional characterization of the putative protein 8b of the severe acute respiratory syndrome-associated coronavirus. FEBS Lett. 2006;580:3643–48. doi:10.1016/j.febslet.2006.05.051.
   PubMed Web of Science ®Google Scholar
• Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–99. doi:10.1126/science.1085952.
   PubMed Web of Science ®Google Scholar
• Shin G-C, Chung Y-S, Kim I-S, Cho H-W, Kang C. Preparation and characterization of a novel monoclonal antibody specific to severe acute respiratory syndrome-coronavirus nucleocapsid protein. Virus Res. 2006;122:109–18. doi:10.1016/j.virusres.2006.07.004.
   PubMed Web of Science ®Google Scholar
• Narayanan K, Huang C, Makino S. SARS coronavirus accessory proteins. Virus Res. 2008;133:113–21. doi:10.1016/j.virusres.2007.10.009.
   PubMed Web of Science ®Google Scholar
• Nguyen TTH, Ryu H-J, Lee S-H, Hwang S, Breton V, Rhee JH, Kim D. Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation. Bioorg Med Chem Lett. 2011;21:3088–91. doi:10.1016/j.bmcl.2011.03.034.
   PubMed Web of Science ®Google Scholar
• Liu DX, Fung TS, Chong KKL, Shukla A, Hilgenfeld R. Accessory proteins of SARS-CoV and other coronaviruses. Antivir Res. 2014;109:97–109. doi:10.1016/j.antiviral.2014.06.013.
   PubMed Web of Science ®Google Scholar
• Spiegel M, Pichlmair A, Martinez-Sobrido K, Cros J, Garcia-Sastre A, Haller O, Weber F. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol. 2005;79:2079–86. doi:10.1128/JVI.79.4.2079-2086.2005.
   PubMed Web of Science ®Google Scholar
• Spiegel M, Pichlmair A, Muhlberger E, Haller O, Weber F. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2004;30:211–13. doi:10.1016/j.jcv.2003.11.013.
   Web of Science ®Google Scholar
• Zheng B, He M-L, Wong K-L, Lum CT, Poon LLM, Peng Y, Guan Y, Lin MCM, Kung H-F. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). J Interferon Cytokine Res. 2004;24:388–90. doi:10.1089/1079990041535610.
   PubMed Web of Science ®Google Scholar
• He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, Jiang S. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol. 2004;173:4050–57. doi:10.4049/jimmunol.173.6.4050.
   PubMed Web of Science ®Google Scholar
• Gallagher TM, Buchmeier MJ. Coronavirus spike proteins in viral entry and pathogenesis. Virology. 2001;279:371. doi:10.1006/viro.2000.0757.
   PubMed Web of Science ®Google Scholar
• Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest. 2003;111:1605. doi:10.1172/JCI18819.
   PubMed Web of Science ®Google Scholar
• Holmes KV. SARS-associated coronavirus. N Engl J Med. 2003;348:1948. doi:10.1056/NEJMp030078.
   PubMed Web of Science ®Google Scholar
• Gebauer F, Posthumus WP, Correa I, Sune C, Smerdou C, Sanchez CM, Lenstra JA, Meloen RH, Enjuanes L. Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein. Virology. 1991;183:225. doi:10.1016/0042-6822(91)90135-X.
   PubMed Web of Science ®Google Scholar
• Posthumus WP, Lenstra JA, van Nieuwstadt AP, Schaaper WM, van der Zeijst BA, Meloen RH. Immunogenicity of peptides simulating a neutralization epitope of transmissible gastroenteritis virus. Virology. 1991;182:371. doi:10.1016/0042-6822(91)90684-4.
   PubMed Web of Science ®Google Scholar
• Enjuanes L, Sune F, Gebauer C, Smerdou C, Camacho A, Anton IM, Gonzalez S, Talamillo A, Mendez A, Ballesteros ML, et al. Antigen selection and presentation to protect against transmissible gastroenteritis coronavirus. Vet Microbiol. 1992;33:249. doi:10.1016/0378-1135(92)90053-V.
   PubMed Web of Science ®Google Scholar
• Li G, Chen X, Xu A. Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med. 2003;349:508. doi:10.1056/NEJM200307313490520.
   PubMed Web of Science ®Google Scholar
• Kuo L, Masters PS. The small envelope protein E is not essential for murine coronavirus replication. J Virol. 2003;77:4597–608. doi:10.1128/JVI.77.8.4597-4608.2003.
   PubMed Web of Science ®Google Scholar
• Ortego J, Ceriani JE, Patino C, Plana J, Enjuanes L. Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway. Virology. 2007;368(2):296–308. doi:10.1016/j.virol.2007.05.032.
   PubMed Web of Science ®Google Scholar
• DeDiego ML, Nieto-Torres JL, Jimenez-Guardeno JM, Regla-Nava JA, Castano-Rodriguez C, Fernandez-Delgado R, Usera F, Enjuanes L. Coronavirus virulence genes with main focus on SARS-CoV envelope gene. Virus Res. 2014;194:124–37. doi:10.1016/j.virusres.2014.07.024.
   PubMed Web of Science ®Google Scholar
• DeDiego MK, Nieto-Torres JL, Jimenez-Guardeno JM, Regla-Nava JA, Alvarez E, Oliveros JC, Zhao J, Fett C, Perlman S, Enjuanes L. Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog. 2011;7:e1002315. doi:10.1371/journal.ppat.1002315.
   PubMed Web of Science ®Google Scholar
• Nieto-Torres JL, DeDiego ML, Verdia-Baguena C, Jimenez-Guardeno JM, Regla-Nava JA, Fernandez-Delgado R, Castano-Rodriguez C, Alcaraz A, Torres J, Aguilella VM, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014. http://dx.doi.10.1371/journal.ppat.1004077.
   Web of Science ®Google Scholar
• Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020. doi:10.1038/s41591-020-0820-9.
   PubMed Web of Science ®Google Scholar
• Li T. Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0). Emerg Microbes Infect. 2020;9:582–85.
   PubMed Web of Science ®Google Scholar
• Ceccarelli M, Berretta M, Venanzi Rullo E, Nunnari G, Cacopardo B. Editorial- difference and similarities between severe acute respiratory syndrome (SARS)- Coronavirus (CoV) an SARS-CoV-2. Would a rose by another name smell as sweet? Eur Rev Med Pharmacol Sci. 2020;24:2781–83.
   PubMed Web of Science ®Google Scholar
• Chee YC. Severe acute respiratory syndrome (SARS)-150 days on. Ann Acad Med Singapore. 2003;32:277–80.
   PubMed Web of Science ®Google Scholar
• Kissoon N. The threat of severe acute respiratory syndrome (SARS). West Indian Med J. 2003;52:91–94.
   PubMed Web of Science ®Google Scholar
• Thomas PA. Severe acute respiratory syndrome (SARS): a bolt from the blue. Indian J Med Microbiol. 2003;21:150–51.
   PubMedGoogle Scholar
• Chowell G, Fenimore PW, Castillo-Garsow MA, Castillo-Chavez C. SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism. J Theor Biol. 2003;224:1–8. doi:10.1016/S0022-5193(03)00228-5.
   PubMed Web of Science ®Google Scholar
• Lang Z-W, Zhang L-J, Zhang S-J, Meng X, Li J-Q, Song C-Z, Sun L, Zhou Y-S, Dwyer DE. A clinicopathological study of three cases of severe acute respiratory syndrome (SARS). Pathology. 2003;35(6):526–31. doi:10.1080/00313020310001619118.
   PubMed Web of Science ®Google Scholar
• Ruiz-Contreras A. Case report: caring for suspected severe acute respiratory syndrome (SARS) patients. Dis Manage Response. 2003;1(3):71–75. doi:10.1016/S1540-2487(03)00045-2.
   PubMedGoogle Scholar
• Hawkey PM, Bhagani S, Gillespie SH. Severe acute respiratory syndrome (SARS): breath-taking progress. J Med Microbiol. 2003;52:609–13. doi:10.1099/jmm.0.05321-0.
   PubMed Web of Science ®Google Scholar
• Stohr K. World Health Organization multicentre collaborative network for severe acute respiratory syndrome (SARS) diagnosis. A multi-centre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet. 2003;361:1730–33. doi:10.1016/S0140-6736(03)13376-4.
   PubMedGoogle Scholar
• Hoheisel G, Luk WK, Winkler J, Gillissen A, Wirtz H, Liebert Y, Hui DS. Severe acute respiratory syndrome (SARS). Med Klin. 2007;101(12):957–63. doi:10.1007/s00063-006-1127-4.
   Google Scholar
• Patrick DM. The race to outpace severe acute respiratory syndrome (SARS). Can Med Assoc J. 2003;168:1265–66.
   Web of Science ®Google Scholar
• Shin G-C, Chung Y-S, Kim I-S, Cho H-W, Kang C. Antigenic characterization of severe acute respiratory syndrome-coronavirus nucleocapsid protein expressed in insect cells: the effect of phosphorylation on immunoreactivity and specificity. Virus Res. 2007;127:71–80. doi:10.1016/j.virusres.2007.03.019.
   PubMed Web of Science ®Google Scholar
• Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019;33(4):869–89. doi:10.1016/j.idc.2019.07.001.
   PubMed Web of Science ®Google Scholar
• Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003. doi:10.1001/jama.289.21.JOC30885.
   PubMedGoogle Scholar
• Chan-Yeung M, Yu WC. Outbreak of severe acute respiratory syndrome in Hong Kong special administrative region: case report. BMJ. 2003;326:850–52. doi:10.1136/bmj.326.7394.850.
   PubMedGoogle Scholar
• Leung WK, To K-F, Chan PKS, Chan HLY, Wu AKL, Lee N, Yuen KY, Sung JJY. Enteric involvement of severe acute respiratory syndrome associated coronavirus infection. Gastroenterology. 2003;125:1011–17. doi:10.1016/j.gastro.2003.08.001.
   PubMed Web of Science ®Google Scholar
• Zhong NS. The clinical diagnosis and treatment of SARS at present. Zhong Guoyi Xuelun Tanbao. 2003;4:29.
   Google Scholar
• Aronin SI, Sadigh M. Severe acute respiratory syndrome. Conn Med. 2004;68:207–15.
   PubMedGoogle Scholar
• Shen B, Cheng SKW, Lau KK, Li HL, Chan ELY. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatr. 2005;20:236–42. doi:10.1016/j.eurpsy.2004.06.023.
   PubMed Web of Science ®Google Scholar
• Lien T-C, Sung C-S, Lee C-H, Kao H-K, Huang Y-C, Liu C-Y, Perng R-P, Wang J-H. Characteristic features and outcomes of severe acute respiratory syndrome found in severe acute respiratory syndrome intensive care unit patients. J Crit Care. 2008;23:557–64. doi:10.1016/j.jcrc.2007.05.004.
   PubMed Web of Science ®Google Scholar
• Ahmad A, Krumkamp R, Reintje R. Controlling SARS: a review on China,s response compared with other SARS-affected countries. Trop Med Int Health. 2009;14(1):36–45. doi:10.1111/j.1365-3156.2008.02146.x.
   PubMedGoogle Scholar
• Wang W, Ruan S. Simulating the SARS outbreak in Beijing with limited data. J Theor Biol. 2004;227:369–79. doi:10.1016/j.jtbi.2003.11.014.
   PubMed Web of Science ®Google Scholar
• Derrick JL, Gomersall CD. Protecting healthcare staff from severe acute respiratory syndrome: filtration capacity of multiple surgical masks. J Hosp Infect. 2005;59:365–68. doi:10.1016/j.jhin.2004.10.013.
   PubMed Web of Science ®Google Scholar
• Bryce E, Copes R, Gamage B, Lockhart K, Yassi A. Staff perception and institutional reporting: two views of infection control compliance in British Columbia and Ontario three years after an outbreak of severe acute respiratory syndrome. J Hosp Infect. 2008;69:169–76. doi:10.1016/j.jhin.2008.03.010.
   PubMed Web of Science ®Google Scholar
• Tsui WMS. Coronavirus is the cause of the severe acute respiratory syndrome (SARS) outbreak in Hong Kong and worldwide. Adv Anat Pathol. 2003;10(4):236. doi:10.1097/00125480-200307000-00008.
   Google Scholar
• Tong TR. Severe acute respiratory syndrome coronavirus (SARS-CoV). Perspect Med Virol. 2006;16:43–95.
   Google Scholar
• Wang H, Rao S, Jiang C. Molecular pathogenesis of severe acute respiratory syndrome. Microbes Infect. 2007;9:119–26. doi:10.1016/j.micinf.2006.06.012.
   PubMed Web of Science ®Google Scholar
• Wong CKK, Lai V, Wong YC. Comparison of initial high resolution computed tomography features in viral pneumonia between metapneumovirus infection and severe acute respiratory syndrome. Eur J Radiol. 2012;81:1083–87. doi:10.1016/j.ejrad.2011.02.050.
   PubMed Web of Science ®Google Scholar
• Poon LLM, Chan KH, Nicholls JM, Zheng BJ, Yuen KY, Guan Y, Peiris JSM. Characterization of a novel coronavirus responsible for severe acute respiratory syndrome. Int Congr Ser. 2004;1263:805–08. doi:10.1016/j.ics.2004.02.105.
   PubMedGoogle Scholar
• Li G-M, Li Y-G, Yamate M, Li S-M, Ikuta K. Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect. 2007;9:96–102. doi:10.1016/j.micinf.2006.10.015.
   PubMed Web of Science ®Google Scholar
• Hafeez R, Aslam M, Aman S, Tahir M. Severe acute respiratory syndrome (SARS): a deadly disease. Ann King Edw Med Univ Pak. 2016;10(1).
   Google Scholar
• Wang ZG, Xu SP, Zhang YJ. The possible origin of recent human SARS coronavirus isolate from China. Acta Virol. 2006;50:211–13.
   PubMed Web of Science ®Google Scholar
• Centers for disease control and prevention: updated interim US case definition for severe acute respiratory syndrome (SARS). URL: http://www.cdc.gov/ncidod/sars/casedefinition.htm
   Google Scholar
• Woodhead M, Ewig S, Torres A. Severe acute respiratory syndrome (SARS). Eur Respir J. 2003;21:739–40. doi:10.1183/09031936.03.00035403.
   PubMed Web of Science ®Google Scholar
• Dolan SA. A new disease emerges: severe acute respiratory syndrome (SARS). J Spec Pediatr Nurs. 2003;8(2):75–76. doi:10.1111/j.1744-6155.2003.tb00190.x.
   PubMedGoogle Scholar
• Wenzel RP, Bearman G, Edmond MB. Lessons from severe acute respiratory syndrome (SARS): implications for infection control. Arch Med Res. 2005;36:610–16. doi:10.1016/j.arcmed.2005.03.040.
   PubMed Web of Science ®Google Scholar
• Xu C, Wang J, Wang L, Cao C. Spatial pattern of severe acute respiratory syndrome in-out flow in 2003 in mainland China. BMC Infect Dis. 2014. doi:10.1186/s12879-014-0721-y.
   Web of Science ®Google Scholar
• Parashar UD, Anderson LJ. Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol. 2004;33:628–34. doi:10.1093/ije/dyh198.
   PubMed Web of Science ®Google Scholar
• Nie Q-H, Luo X-D, Hui W-L. Advances in clinical diagnosis and treatment of severe acute respiratory syndrome. World J Gastroenterol. 2003;9(6):1139–43. doi:10.3748/wjg.v9.i6.1139.
   PubMed Web of Science ®Google Scholar
• Fujii T, Nakamura T, Iwamoto A. Current concepts in SARS treatment. J Infect Chemother. 2004;10:1–7. doi:10.1007/s10156-003-0296-9.
   PubMedGoogle Scholar
• Cheung TMT, Yam LYC, Lau ACW, Kong BMH, Yung RWH. Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. CHEST. 2004;126:845–50. doi:10.1378/chest.126.3.845.
   PubMed Web of Science ®Google Scholar
• Wong HH, Fung TS, Fang S, Huang M, Le MT, Liu DX. Accessory proteins 8b and 8ab of severe acute respiratory syndrome coronavirus suppress the interferon signaling pathway by mediating ubiquitin-dependent rapid degradation of interferon regulatory factor 3. Virology. 2018;515:165–75. doi:10.1016/j.virol.2017.12.028.
   PubMed Web of Science ®Google Scholar
• Keyaerts E, Vijgen L, Maes P, Neyts J, Ranst MV. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004;323:264–68. doi:10.1016/j.bbrc.2004.08.085.
   PubMed Web of Science ®Google Scholar
• Lau EHY, Cowling BJ, Muller MP, Ho L-M, Tsang T, LoS V, Louie M, Leung GM. Effectiveness of ribavirin and corticosteroids for severe acute respiratory syndrome. Am J Med. 2009;122(12). doi:10.1016/j.amjmed.2009.07.018.
   PubMed Web of Science ®Google Scholar
• Peiris JSM. Severe acute respiratory syndrome (SARS). J Clin Virol. 2003;28(3):245–47. doi:10.1016/j.jcv.2003.08.005.
   PubMed Web of Science ®Google Scholar
• Hui DSC, Chan PKS. Severe acute respiratory syndrome and coronavirus. Infect Dis Clin North Am. 2010;24(3):619–38. doi:10.1016/j.idc.2010.04.009.
   PubMed Web of Science ®Google Scholar
• Ding Y-Q, He L, Zhang Q, Huang Z, Che X, Hou J-L, Wang H, Shen H, Qiu L, Li Z, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622–30. doi:10.1002/path.1560.
   PubMed Web of Science ®Google Scholar
• Wu G, Yan S. Potential targets for anti-SARS drugs in the structural proteins from SARS related to coronavirus. Peptides. 2004;25(6):901–08. doi:10.1016/j.peptides.2004.03.002.
   PubMed Web of Science ®Google Scholar
• Lu J-H, Zhang D-M, Wang G-L, Guo Z-M, Zhang C-H, Tan B-Y, Ouyang L-P, Lin L, Liu Y-M, Chen W-Q, et al. Variation analysis of the severe acute respiratory syndrome coronavirus putative non-structural protein 2 gene and construction of three-dimensional model. Chin Med J. 2005;118:707–13.
   PubMed Web of Science ®Google Scholar
• Rabenau HF, Kampf G, Cinatl J, Doerr HW. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect. 2005;61(2):107–11. doi:10.1016/j.jhin.2004.12.023.
   PubMed Web of Science ®Google Scholar
• Cao C, Chen W, Zheng S, Zhao J, Wang J, Cao W. Analysus of spatiotemporal characteristics of pandemic SARS spread in mainland China. Biomed Res Int. 2016;12.
   Google Scholar
• Demmler GJ, Ligon BL. Severe acute respiratory syndrome (SARS): a review of the history, epidemiology, prevention and concerns for the future. Semin Pediatr Infect Dis. 2003;14(3):240–44. doi:10.1016/S1045-1870(03)00056-6.
   PubMedGoogle Scholar
• Maxwell C, McGeer A, Tai KFY, Sermer MN. 225-management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS). J Obstet Gynaecol Can. 2017;39(8):e130–e137. doi:10.1016/j.jogc.2017.04.024.
   PubMed Web of Science ®Google Scholar
• Yount B, Curtis KM, Fritz EA, Hensley LE, Jahrling PB, Prentice E, Denison MR, Geisbert TW, Baric RS. Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. PNAS. 2003;100(22):12995–3000. doi:10.1073/pnas.1735582100.
   PubMed Web of Science ®Google Scholar
• Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136–47. doi:10.2353/ajpath.2007.061088.
   PubMed Web of Science ®Google Scholar
• Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1420–27. doi:10.1086/420743.
   PubMed Web of Science ®Google Scholar
• Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N, et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19(Suppl 1):S12–8. doi:10.26719/2013.19.supp1.S12.
   PubMed Web of Science ®Google Scholar
• Chan JFW, Lau SKP, To KKW, Cheng VCC, Woo PCY, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015;28(2):465–522. doi:10.1128/CMR.00102-14.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Memish ZA. Drivers of MERS-CoV transmission: what do we know? Expert Rev Respir Med. 2016;10:331–38. doi:10.1586/17476348.2016.1150784.
   PubMed Web of Science ®Google Scholar
• Kim Y, Lee S, Chu C, Choe S, Hong S, Shin Y. The characteristics of middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea. Osong Public Health Res Perspect. 2016;7:49–55. doi:10.1016/j.phrp.2016.01.001.
   PubMedGoogle Scholar
• Jung S-Y, Kang KW, Lee E-Y, Seo D-W, Kim H-L, Kim H, Kwon TW, Park H-L, Kim H, Lee S-M, et al. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine. 2018;36:3468–76. doi:10.1016/j.vaccine.2018.04.082.
   PubMed Web of Science ®Google Scholar
• Ko J-H, Kim S-H, Lee NY, Kim Y-J, Cho SY, Kang C-I, Chung DR, Peck KR. Effects of environmental disinfection on the isolation of vancomycin-resistant Enterococcus after a hospital-associated outbreak of Middle East respiratory syndrome. Am J Infect Control. 2019;47:1516–18. doi:10.1016/j.ajic.2019.05.032.
   PubMed Web of Science ®Google Scholar
• De, Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013;87:7790–92. doi:10.1128/JVI.01244-13.
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–20. doi:10.1056/NEJMoa1211721.
   PubMed Web of Science ®Google Scholar
• Eifan SA, Nour I, Hanif A, Zamzam AMM, Aljohani SM. A pandemic risk assessment of middle east respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia. Saudi J Biol Sci. 2017;24:1631–38. doi:10.1016/j.sjbs.2017.06.001.
   PubMed Web of Science ®Google Scholar
• Adegboye O, Saffary T, Adegboye M, Elfaki F. Individual and network characteristics associated with hospital-acquired Middle East Respiratory Syndrome coronavirus. J Infect Public Health. 2019;12:343–49. doi:10.1016/j.jiph.2018.12.002.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV): Thailand. Disease outbreak news. World Health Organization; 2015. http://www.who.int/csr/don/20-june-2015-mers-thailand/en/
   Google Scholar
• Cha MJ, Chung MJ, Kim K, Lee KS, Kim TJ, Kim TS. Clinical implication of radiographic scores in acute Middle East respiratory syndrome coronavirus pneumonia: report from a single tertiary-referral center of South Korea. Eur J Radiol. 2018;107:196–202. doi:10.1016/j.ejrad.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Yavarian J, Shafiei Jandaghi NZ, Naseri M, Hemmati P, Dadras M, Gouya MM, Azad TM. Influenza virus but not MERS coronavirus circulation in Iran, 2013–2016: comparison between pilgrims and general population. Travel Med Infect Dis. 2018;21:51–55. doi:10.1016/j.tmaid.2017.10.007.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Memish ZA. Emerging respiratory viral infections: MERS-CoV and influenza. Lancet Respir Med. 2014;2(1):23–25. doi:10.1016/S2213-2600(13)70255-8.
   PubMed Web of Science ®Google Scholar
• Almaghrabi RS, Omrani AS. Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Br J Hosp Med (Lond). 2017;78(1):23–26. doi:10.12968/hmed.2017.78.1.23.
   PubMed Web of Science ®Google Scholar
• Mailles A, Blanckaert K, Chaud P, van der Werf S, Lina B, Caro V, et al. First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill. 2013;18(24).
   PubMedGoogle Scholar
• Choudhry H, Bakhrebah MA, Abdulaal WH, Zamzami MA, Baothman OA, Hassan MA, Zeyadi M, Helmi N, Alzahrani FA, Ali A, et al. Middle East respiratory syndrome: pathogenesis and therapeutic developments. Future Virol. 2019;14(4):237–46. doi:10.2217/fvl-2018-0201.
   PubMed Web of Science ®Google Scholar
• Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatid ZN, Assad M, Almulhim A, Makhdoom H, et al. Hospital outbreak or Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369(5):407–16. doi:10.1056/NEJMoa1306742.
   PubMed Web of Science ®Google Scholar
• Arabi YM, Arifi AA, Kalkhy HH, Najm H, Aldawwod AS, Ghabashi A, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389–97. doi:10.7326/M13-2486.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Zumla A, Memish ZA. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med Infect Dis. 2014;12:422–28. doi:10.1016/j.tmaid.2014.06.007.
   PubMed Web of Science ®Google Scholar
• Noorwali AA, Turkistani AM, Asiri SI, Trabulsi FA, Alwafi OM, Alzahrani SH, et al. Descriptive epidemiology and characteristics of confirmed cases of Middle East respiratory syndrome coronavirus infection in the Makkah Region of Saudi Arabia. March to June 2014. Ann Saudi Med. 2015;35:203–09. doi:10.5144/0256-4947.2015.203.
   PubMed Web of Science ®Google Scholar
• Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N, et al. IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. Antimicrob Chemother. 2015;70:2129–32. doi:10.1093/jac/dkv085.
   Google Scholar
• Memish ZA, Zumla AI, Assiri A. Middle East respiratory syndrome coronavirus infections in health care workers. N Eng J Med. 2013;369:884–86. doi:10.1056/NEJMc1308698.
   PubMed Web of Science ®Google Scholar
• Memish ZA, Al-Tawfiq JA. Middle East respiratory syndrome coronavirus infection control: the missing piece? Am J Infect Control. 2014;42. doi:10.1016/j.ajic.2014.08.003.
   Web of Science ®Google Scholar
• Assiri A, Abedi GR, Saeed AAB, Abdalla MA, al-Masry M. Multifacility outbreak of Middle East respiratory syndrome in Tarif. Saudi Arabia Emerg Infect Dis. 2016;22:32–40. doi:10.3201/eid2201.151370.
   PubMed Web of Science ®Google Scholar
• Hui DS, Perlman S, Zumla A. Spread of MERS to South Korea and China. Lancet Respir Med. 2015;3:509–10. doi:10.1016/S2213-2600(15)00238-6.
   PubMed Web of Science ®Google Scholar
• De Wit E, Munster VJ. MERS-CoV: the intermediate host identified? Lancet Infect Dis. 2013;13:827–28. doi:10.1016/S1473-3099(13)70193-2.
   PubMed Web of Science ®Google Scholar
• Corman VM, Olschlager S, Wendtner C-M, Drexler JF, Hess M, Drosten C. Performance and clinical validation of the RealStar MERS-CoV kit for detection of Middle East respiratory syndrome coronavirus RNA. J Clin Virol. 2014;60:168–71. doi:10.1016/j.jcv.2014.03.012.
   PubMed Web of Science ®Google Scholar
• Munster VJ, Adney DR, van Doremalen N, Brown VR, Miazgowicz KL, Milne-Price S, Bushmaker T, Rosenke R, Scott D, Hawkinson A, et al. Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis). Sci Rep. 2016;6:21878. doi:10.1038/srep21878.
   PubMed Web of Science ®Google Scholar
• Meyerholz DK, Lambertz AM, McCray Jr PB. Dipeptidyl peptidase 4 distribution in the human respiratory tract. Am J Pathol. 2016;186(1):78–86. doi:10.1016/j.ajpath.2015.09.014.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Middle East respiratory syndrome coronavirus [MERS-CoV]; 2016. (http://www,who.int/emergencies/mers-cov/en/)
   Google Scholar
• Alagaili AN, Briese T, Amor NMS, Mohammed OB, Lipkin WI. Waterpipe smoking as a public health risk: potential risk for transmission of MERS-CoV. Saudi J Biol Sci. 2019;26:938–41. doi:10.1016/j.sjbs.2018.05.006.
   PubMed Web of Science ®Google Scholar
• Poissy J, Goffard A, Parmentier-Decruq E, Favory R, Kauv M, Kipnis E, Mathieu D, Guery B. The MERS-CoV Biology Group. 2014. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol. 2014;61:275–78. doi:10.1016/j.jcv.2014.07.002.
   PubMed Web of Science ®Google Scholar
• Faridi U. Middle East respiratory syndrome coronavirus (MERS-CoV): impact on Saudi Arabia, 2015. Saudi J Biol Sci. 2018;25:1402–05. doi:10.1016/j.sjbs.2016.09.020.
   PubMed Web of Science ®Google Scholar
• Amer H, Alqahtani AS, Alaklobi F, Altayeb J, Memish ZA. Healthcare worker exposure to Middle East respiratory syndrome coronavirus (MERS-CoV): revision of screening strategies urgently needed. Int J Infect Dis. 2018;71:113–16. doi:10.1016/j.ijid.2018.04.001.
   PubMed Web of Science ®Google Scholar
• Park SY, Lee JS, Son JS, Ko JH, Peck KR, Jung Y, Woo HJ, Joo YS, Eom JS, Shi H. Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers. J Hosp Infect. 2019;101:42–46. doi:10.1016/j.jhin.2018.09.005.
   PubMed Web of Science ®Google Scholar
• Chowell G, Blumberg S, Simonsen L, Miller MA, Viboud C. Synthesizing data and models for the spread of MERS-CoV, 2013; key role of index cases and hospital transmission. Epidemics. 2014;9:40–51. doi:10.1016/j.epidem.2014.09.011.
   PubMed Web of Science ®Google Scholar
• Cowling BJ, Park M, Fang VJ, Wu P, Leung GM, Wu JT. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Eurosurveillance. 2015;20(25). doi:10.2807/1560-7917.ES2015.20.25.21163.
   Web of Science ®Google Scholar
• Kucharski AJ, Althaus CL. The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission. Eurosurveillance. 2015;20(25). doi:10.2807/1560-7917.ES2015.20.25.21167.
   Web of Science ®Google Scholar
• Al-Jasser FS, Nouh RM, Youssef RM. Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014–2015. J Infect Public Health. 2019;12:171–77. doi:10.1016/j.jiph.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Poletto C, Gomes MF, Pastore Y, Piontti A, Rossi L, Bioglio L, Chao DL, Longini IM, Halloran ME, Colizza A, et al. Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. Euro Surveill. 2014;19(42). doi:10.2807/1560-7917.ES2014.19.42.20936.
   Google Scholar
• Bogoch II, Creatore MI, Cetron MS, Brownstein JS, Pesik N, Miniota J, Tam T, Hu W, Nicolucci A, Ahmed S, et al. Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak. Lancet. 2015;385(9962):29–35. doi:10.1016/S0140-6736(14)61828-6.
   PubMed Web of Science ®Google Scholar
• Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013;23(8):986–93. doi:10.1038/cr.2013.92.
   PubMed Web of Science ®Google Scholar
• Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15:327–47. doi:10.1038/nrd.2015.37.
   PubMed Web of Science ®Google Scholar
• Wernery U, Lau SKP, Woo PCY. Middle East respiratory syndrome (MERS) coronavirus and dromedaries. Vet J. 2017;220:75–79. doi:10.1016/j.tvjl.2016.12.020.
   PubMed Web of Science ®Google Scholar
• Haverkamp A-K, Bosch BJ, Spitzbarth I, Lehmbecker A, Te N, Bensaid A, Segales J, Baumgartner W. Detection of MERS-CoV antigen on formalin-fixed paraffin-embedded nasal tissue of alpacas by immunohistochemistry using human monoclonal antibodies directed against different epitopes of the spike protein. Vet Immunol Immunopathol. 2019;218:109939. doi:10.1016/j.vetimm.2019.109939.
   PubMed Web of Science ®Google Scholar
• Lu G, Hu Y, Wang Q, Qi J, Gao F, Li Y, Zhang Y, Zhang W, Yuan Y, Bao J, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013;500:227–31. doi:10.1038/nature12328.
   PubMed Web of Science ®Google Scholar
• Inn K-S, Kim Y, Aigerim A, Park U, Hwang E-S, Choi M-S, Kim Y-S, Cho N-H. Reduction of soluble dipeptidyl peptidase 4 levels in plasma of patients infected with Middle East respiratory syndrome coronavirus. Virology. 2018;518:324–27. doi:10.1016/j.virol.2018.03.015.
   PubMed Web of Science ®Google Scholar
• Li W, Hulswit RJG, Widjaja I, Raj VS, McBride R, Peng W, Widagdo W, Tortotici MA, van Dieren B, Lang Y, et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc Natl Acad Sci U S A. 2017;114:E8508–E8517. doi:10.1073/pnas.1712592114.
   PubMed Web of Science ®Google Scholar
• Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S. MERS-CoV spike protein: a key target for antivirals. Expert Opin Ther Targets. 2017;21:131–43. doi:10.1080/14728222.2017.1271415.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wong G, Lu G, Yan J, Gao GF. MERS-CoV spike protein: targets for vaccines and therapeutics. Antiviral Res. 2016;133:165–77. doi:10.1016/j.antiviral.2016.07.015.
   PubMed Web of Science ®Google Scholar
• Du LY, He YX, Zhou YS, Liu SW, Zheng BJ, Jiang SB. The spike protein of SARS-CoV- a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7:226–36. doi:10.1038/nrmicro2090.
   PubMed Web of Science ®Google Scholar
• Zhang N, Jiang S, Du L. Current advancements and potential strategies in the development of MERS-CoV vaccines. Expert Rev Vaccines. 2014;13:761–74. doi:10.1586/14760584.2014.912134.
   PubMed Web of Science ®Google Scholar
• Papaneri AB, Johnson RF, Wada J, Bollinger L, Jahrling PB, Kuhn JH. Middle East respiratory syndrome: obstacles and prospects for vaccine development. Expert Rev Vaccines. 2015;14:949–62. doi:10.1586/14760584.2015.1036033.
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, Dekkers DHW, Muller MA, Dijkman R, Muth D, Demmers JAA, Zaki A, Fouchier RAM, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251–54. doi:10.1038/nature12005.
   PubMed Web of Science ®Google Scholar
• Pallesen J, Wang N, Corbett KS, Warpp D, Kirchdoerfer RN, Turner HL, Cottrell CA, Becker MM, Wang L, Shi W, et al. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A. 2017;114:E7348–E7357. doi:10.1073/pnas.1707304114.
   PubMed Web of Science ®Google Scholar
• Meyer B, Muller MA, Corman VM, Reusken CB, Ritz D, Godeke GJ, Lattwein E, Kallies S, Siemens A, van Beek J, et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis. 2014;20(4):552–59. doi:10.3201/eid2004.131746.
   PubMed Web of Science ®Google Scholar
• Muller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, Sieberg A, Aldabbagh S, Bosch BJ, Lattwein E, et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis. 2015;15(5):559–64. doi:10.1016/S1473-3099(15)70090-3.
   PubMed Web of Science ®Google Scholar
• Song F, Fux R, Provacia LB, Volz A, Eickmann M, Becker S, et al. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccine virus Ankara efficiently induces virus-neutralizing antibodies. J Virol. 2013;87:11950–54. doi:10.1128/JVI.01672-13.
   PubMed Web of Science ®Google Scholar
• Kim E, Okada K, Kenniston T, Raj VS, AlHajri MN, Farag EA, et al. Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB/c mice. Vaccine. 2014;32:5975–82. doi:10.1016/j.vaccine.2014.08.058.
   PubMed Web of Science ®Google Scholar
• Guo X, Deng Y, Chen H, Lan J, Wang W, Zou X, et al. Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus. Immunology. 2015;145:476–84. doi:10.1111/imm.12462.
   PubMed Web of Science ®Google Scholar
• Volz A, Kupke A, Song F, Jany S, Fux R, Shams-Eldin H, et al. Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein. J Virol. 2015;89(16):8651–56. doi:10.1128/JVI.00614-15.
   PubMed Web of Science ®Google Scholar
• Alharbi NK, Padron-Regalado E, Thompson CP, Kupke A, Wells D, Sloan MA, et al. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralizing antibodies and cellular immune responses in mice. Vaccine. 2017;35:3780–88. doi:10.1016/j.vaccine.2017.05.032.
   PubMed Web of Science ®Google Scholar
• Ma C, Li Y, Wang L, Zhao G, Tao X, Tseng CT, et al. Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines. Vaccine. 2014;32(18):2100–08. doi:10.1016/j.vaccine.2014.02.004.
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang N, Tao X, Zhao G, Guo Y, Tseng CT, et al. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus. Hum Vaccin Immunother. 2015;11:1244–50. doi:10.1080/21645515.2015.1021527.
   PubMed Web of Science ®Google Scholar
• Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, Flyer DC, et al. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine. 2017;35(12):1586–89. doi:10.1016/j.vaccine.2017.02.012.
   PubMed Web of Science ®Google Scholar
• Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, et al. Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015;6:7712. doi:10.1038/ncomms8712.
   PubMed Web of Science ®Google Scholar
• Muthumani K, Falzarano D, Reuschel EL, Tingey C, Flingai S, Villarreal DO, et al. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015;7(301):301ra132. doi:10.1126/scitranslmed.aac7462.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Pear TM. Middle East respiratory syndrome coronavirus in healthcare settings. Curr Opin Infect Dis. 2015;28:392–96. doi:10.1097/QCO.0000000000000178.
   PubMed Web of Science ®Google Scholar
• Ahmadzadeh J, Mobaraki K, Mousavi SJ, Aghazadeh-Attari J, Mirza-Aghazadeh-Attari M, Mohebbi I. The risk factors associated with MERS-CoV patient fatality: a global survey. Diagn Microbiol Infect Dis. 2020;96:114876. doi:10.1016/j.diagmicrobio.2019.114876.
   PubMed Web of Science ®Google Scholar
• Nah K, Otsuki S, Chowell G, Nishiura H. Predicting the international spread of Middle East respiratory syndrome (MERS). BMC Infect Dis. 2016;16:356.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun J, Zhu A, Zhao J, Zhao J. Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models. J Thorac Dis. 2018;10:S2260–S2271.
   PubMed Web of Science ®Google Scholar
• Al-Omari A, Rabaan AA, Salih S, Al-Tawfiq JA, Memish ZA. MERS coronavirus outbreak: implications for emerging viral infections. Diagn Microbiol Infect Dis. 2019;93:265–85.
   PubMed Web of Science ®Google Scholar
• Masters PS. Coronavirus genomic RNA packaging. Virology. 2019;537:198–207.
   PubMed Web of Science ®Google Scholar
• Kasem S, Qasim I, Al-Hufofi A, Hashim O, Alkarar A, Abu-Obeida A, Gaafer A, Elfadil A, Zaki A, Al-Romaihi A, et al. Cross-sectional study of MERS-CoV-specific RNA and antibodies in animals that have had contact with MERS patients in Saudi Arabia. J Infect Public Health. 2018;11:331–38.
   PubMed Web of Science ®Google Scholar
• Dighe A, Jombart T, Van Kerkhove MD, Ferguson N. A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: implications for animal vaccination. Epidemics. 2019;29:100350.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Rabaan AA, Hinedi K. Influenza is more common than Middle East respiratory syndrome coronavirus (MERS-CoV) among hospitalized adult Saudi patients. Travel Med Infect Dis. 2017;20:56–60.
   PubMed Web of Science ®Google Scholar
• Alfaraj SH, Al-Tawfiq JA, Assiri AY, Alzahrani NA, Alanazi AA, Memish ZA. Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: a cohort study. Travel Med Infect Dis. 2019;29:48–50.
   PubMed Web of Science ®Google Scholar
• Corman VM, Ithete NL, Richards LR, Schoeman MC, Presier W, Drosten C, Drexler JF. Rooting the phylogenetic tree o Middle East respiratory syndrome coronavirus by characterization of a conspecific virus from and African bat. J Virol. 2014;88:11297–303.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Lee JY, Lee J, Shin YS, Jeon S, Kim DE, Min JS, Song JH, Kim S, Kwon S, et al. Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors. Bioorg Med Chem Lett. 2019;29:126727.
   PubMed Web of Science ®Google Scholar
• Qiu H, Sun S, Xiao H, Feng J, Guo Y, Tai WY, Du L, Zhao G, Zhou Y. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection. Antiviral Res. 2016;132:141–48.
   PubMed Web of Science ®Google Scholar
• Park HY, Lee EJ, Ryu YA, Kim Y, Kim H, Lee H, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Eurosurveillance. 2015;20(June25):21169.
   Google Scholar
• Ahmed AE. Diagnostic delays 537 symptomatic cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia. Int J Infect Dis. 2017;62:47–51.
   PubMed Web of Science ®Google Scholar
• Ahmed AE. Diagnostic delays in Middle East respiratory syndrome coronavirus patients and health systems. J Infect Public Health. 2019;12:767–71.
   PubMed Web of Science ®Google Scholar
• Lee A, Cho J. The impact of city epidemics on rural labor market: the Korean Middle East Respiratory Syndrome case. Japan World Econ. 2017;43:30–40.
   PubMed Web of Science ®Google Scholar
• Tang B, Bragazzi NL, Li Q, Tang S, Xiao Y, Wu J. An updated estimating of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model. 2020;5:248–55.
   PubMedGoogle Scholar
• Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–33.
   PubMed Web of Science ®Google Scholar
• Alqahtani AS, Rashid H, Basyouni MH, Alhawassi TM, BinDhim NF. Public response to MERS-CoV in the Middle East: iPhone survey in six countries. J Infect Public Health. 2017;10:534–40.
   PubMed Web of Science ®Google Scholar
• Almutairi KM, Al Helih EM, Moussa M, Boshaigah AE, Saleh Alajilan A, Vinluan JM, et al. Awareness, attitude, and practices related to coronavirus pandemic among public in Saudi Arabia. Farm Community Health. 2015;38(4):332–40.
   PubMed Web of Science ®Google Scholar
• Kharma MY, Alalwani MS, Amer MF, Tarakji B, Aws G. Assessing of the awareness level of dental students toward Middle East Respiratory Syndrome-coronavirus. J Int Soc Prev Community Dent. 2015;5:163–69.
   PubMed Web of Science ®Google Scholar
• Al-Mohrej OA, Al-Shirian SD, Al-Otaibi SK, Tamim HM, Masuadi EM, Fakhoury HM. Is the Saudi public aware of Middle East respiratory syndrome? J Infect Public Health. 2016;9:259–66.
   PubMed Web of Science ®Google Scholar
• Bawazir A, Al-Mazroo E, Jradi H, Ahmed A, Badir M. MERS-CoV infection: mind the public knowledge gap. J Infect Public Health. 2018;11:89–93.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA. Middle East Respiratory Syndrome-coronavirus infection: an overview. J Infect Public Health. 2013;6:319–22.
   PubMed Web of Science ®Google Scholar
• Hashem AM, Al-Amri SS, Al-Subhi TL, Siddiq LA, Hassan AM, Alawi MM, Alhabbab RY, Hindawi SI, Mohammed OB, Amor NS, et al. Development and validation of different indirect ELISAs for MERS-CoV serological testing. J Immunol Methods. 2019;466:41–46.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Auwaerter PG. Healthcare-associated infections: the hallmark of Middle East respiratory syndrome coronavirus with review of the literature. J Hosp Infect. 2019;101:20–29.
   PubMed Web of Science ®Google Scholar
• Kim Y. Nurses, experiences of care for patients with Middle East respiratory syndrome-coronavirus in South Korea. Am J Infect Control. 2018;46:781–87.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Abdrabalnabi R, Taher A, Mathew S, Rahman KA. Infection control influence of Middle East respiratory syndrome coronavirus: a hospital-based analysis. Am J Infect Control. 2019;47:431–34.
   PubMed Web of Science ®Google Scholar
• Douglas MG, Kocher JF, Scobey T, Baric RS, Cockrell AS. Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease. Virology. 2018;517:98–107.
   PubMed Web of Science ®Google Scholar
• Nikiforuk AM, Leung A, Cook BWM, Court DA, Kobasa D, Theriault SS. Rapid one-step construction of a Middle East Respiratory Syndrome (MERS-CoV) infectious clone system by homologous recombination. J Virol Methods. 2016;236:178–83.
   PubMed Web of Science ®Google Scholar
• Ebihara H, Groseth A, Neumann G, Kawaoka Y, Feldmann H. The role of reverse genetics system in studying viral hemorrhagic fevers. Thromb Haemost. 2005;94:240–53.
   PubMed Web of Science ®Google Scholar
• Letko M, Miazgowicz K, McMinn R, Seifert SN, Sola I, Enjuanes L, Carmody A, van Doremalen N, Munster V. Adaptive evolution of MERS-CoV to species variation in DPP4. Cell Rep. 2018;24:1730–37.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhou P, Wang P, Li Y, Jiang L, Jia W, Wang H, Fan A, Wang D, Shi X, et al. Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein. Cell Rep. 2018;24:441–52.
   PubMed Web of Science ®Google Scholar
• Mustafa S, Balkhy H, Gabere MN. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): a review. J Infect Public Health. 2018;11:9–17.
   PubMed Web of Science ®Google Scholar
• Baharoon S, Memish ZA. MERS-CoV as an emerging respiratory illness: a review of prevention methods. Travel Med Infect Dis. 2019;32:101520.
   PubMed Web of Science ®Google Scholar
• Widagdo W, Okba NMA, Raj VS, Haagmans BL. MERS-coronavirus: from discovery to intervention. One Health. 2017;3:11–16.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang -L-L, Zhao S-J, Kwak-Kim J, Mor G, Liao A-H. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139:103122.
   PubMed Web of Science ®Google Scholar
• Banik GR, Khandaker G, Rashid H. Middle East Respiratory Syndrome Coronavirus “MERS-CoV”: current knowledge gaps. Paediatr Respir Rev. 2015;16:197–202.
   PubMed Web of Science ®Google Scholar
• Cunha CB, Opal SM. Middle East respiratory syndrome (MERS). Virulence. 2014;5:650–54.
   PubMed Web of Science ®Google Scholar
• Hui DS, Azhar E, Kim Y-J, Memish ZA, Oh M-D, Zumla A. Middle East respiratory syndrome coronavirus: risj factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18:e217–227.
   PubMed Web of Science ®Google Scholar
• Arabi Y, Balkhy H, Hajeer AH, et al. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015;4:709.
   PubMed Web of Science ®Google Scholar
• Rabaan AA, Alahmed SH, Bazzi AM, Alhani HM. A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective. J Med Microbiol. 2017;66:1261–74.
   PubMed Web of Science ®Google Scholar
• Sheahan TP, Sims AC, Leist SR, Schafer A, Won J, Brown AJ, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11(1):1–14.
   PubMed Web of Science ®Google Scholar
• Agostini ML, Pruijssers AJ, Chappell JD, et al. Small-molecule antiviral beta-d-n4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance. J Virol. 2019;93:e01348–19.
   PubMed Web of Science ®Google Scholar
• Behzadi MA, Leyva-Grado VH. Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and Middle East respiratory syndrome coronavirus infections. Front Microiol. 2019;10:1327.
   PubMed Web of Science ®Google Scholar
• Beigel JH, Nam HH, Adams PL, et al. Advances in respiratory virus therapeutics- a meeting report from the 6th ISIRV antiviral group conference. Antiviral Res. 2019;167:45–67.
   PubMed Web of Science ®Google Scholar
• Momattin H, Al-Ali AY, Al-Tawfiq JA. A systematic review of therapeutic agents for the treatment of the Middle East respiratory syndrome coronavirus (MERS-CoV). Travel Med Infect Dis. 2019;30:9–18.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang Y, Huang J, Jiang S, Du L. Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain. Viruses. 2019;11:60.
   PubMed Web of Science ®Google Scholar
• Memish ZA, Perlman S, van Kerkove MD, Zumla A. Middle East respiratory syndrome. Lancet. 2020;395:1063–77.
   PubMed Web of Science ®Google Scholar
• Perlman S, Vijay R. Middle East respiratory syndrome vaccines. Middle East respiratory syndrome vaccines. Int J Infect Dis. 2016;47:23–28.
   PubMed Web of Science ®Google Scholar
• Dyall J, Cross R, Kindrachuk J, Johnson RF, Olinger GG, Hensley LE, Frieman MB, Jahrling PB. Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies. Drugs. 2017;77:1935–66.
   PubMedGoogle Scholar
• Tai DYH. Pharmacologic treatment of SARS: current knowledge and recommendations. Ann Acad Med. 2007;36:438–43.
   PubMed Web of Science ®Google Scholar
• Bal A, Destras G, Gaymard A, Bouscambert-Duchamp M, Valette M, Escuret V, Frobert E, Billaud G, Trouillet-Assant S, Cheynet V, et al. Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del). Clin Microbiol Infect. 2020. http://doi.10.1016/j.cmi.2020.03.020.
   Web of Science ®Google Scholar
• Abduljali JM, Abduljali BM. Epidemiology, genome and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes New Infect. 2020. http://doi.10.1016/j.nmni.2020.100672.
   Web of Science ®Google Scholar
• Benvenuto D, Giovanetti M, Vassallo L, Angeletti S, Ciccozzi M. Application of the ARIMA model on the COVID-2019 epidemic dataset. Data Brief. 2020;29:105340.
   PubMed Web of Science ®Google Scholar
• Hsih W-H, Cheng M-Y, Ho M-W, Chou C-H, Lin P-C, Chi C-Y, Liao W-C, Chen C-Y, Leong L-Y, Tien N, et al. Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan. J Microbiol Immunol Infect. 2020. http://doi.10.1016/j.jmii.2020.03.008.
   PubMedGoogle Scholar
• Lai -C-C, Liu YH, Wang C-Y, Wang Y-H, Hsueh S-C, Yen M-Y, Ko W-C, Hsueh P-R. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronaviurs 2(SARS-CoV-2): fact and myths. J Microbiol Immunol Infect. 2020. doi:10.1016/j.jmii.2020.02.012.
   Google Scholar
• Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020. doi:10.1016/j.cmi.2020.03.026.
   Web of Science ®Google Scholar
• Robson B. Computers and viral disease. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventive peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus. Comput Biol Med. 2020;119:103670.
   PubMed Web of Science ®Google Scholar
• Roda WC, Varughese MB, Han D, Li MY. Why is it difficult to accurately predict the COVID-19 epidemic? Infect Dis Model. 2020;5:271–81.
   PubMedGoogle Scholar
• Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020.
   Web of Science ®Google Scholar
• Li C, Yang Y, Ren L. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infect Genet Evol. 2020;82:104285.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020;525:135–40.
   PubMed Web of Science ®Google Scholar
• Cheng S-C, Chang Y-C, Chiang Y-LF, Chien Y-C, Cheng M, Yang C-H, Huang C-H, Hsu Y-N. First case of coronavirus disease 2019 (COVID-19) pneumonia in Taiwan. J Formos Med Assoc. 2020;119:747–51.
   PubMed Web of Science ®Google Scholar
• Yu Jun IS, Anderson DE, Zheng Kang AE, Wang L-F, Rao P, Young BE, Lye DC, Agrawal R. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.03.026.
   Web of Science ®Google Scholar
• Gralinski LE, Menachery VD. Return of the Coronavirus: 2019-nCoV. Viruses. 2020;12:135. doi:10.3390/v12020135.
   PubMed Web of Science ®Google Scholar
• Lupia T, Scabini S, Pinna SM, Di Perri G, De Rosa FG, Corcione S. 2019 novel coronavirus (2019-nCoV) outbreak: a new challenge. J Glob Antimicrob Resist. 2020;21:22–27.
   PubMed Web of Science ®Google Scholar
• Cyranoski D. Mystery deepens over animal source of coronavirus. Nature. 2020;579:18–19. doi:10.1038/d41586-020-00548-w.
   PubMed Web of Science ®Google Scholar
• Ji W, Wang W, Zhao X, Zai J, Li X. Cross species transmission of the newly identified coronavirus 2019-nCoV-Ji-2020. J Med Virol. 2020;92:433–40.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clinica Chimica Acta. 2020;505:190–91.
   PubMed Web of Science ®Google Scholar
• Lu D, Wang H, Yu R, Yang H, Zhao Y. Integrated infection control strategy to minimize nosocomial infection of coronavirus disease 2019 among ENT healthcare workers. J Hosp Infect. 2020. doi:10.1016/j.jhin.2020.02.018.
   Web of Science ®Google Scholar
• Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan. Plos One. 2020;15(3):e0230548. doi:10.1371/journal.pone.0230548.
   PubMed Web of Science ®Google Scholar
• Sun K, Chen J, Viboud C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Lancet Digital Health. 2020;2:e201–208.
   PubMedGoogle Scholar
• Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91–98.
   PubMed Web of Science ®Google Scholar
• Kang S, Peng W, Zhu Y, Lu S, Zhou M, Lin W, Wu W, Huang S, Jiang L, Luo X, et al. Recent progress in understanding 2019 novel coronavirus associated with human respiratory disease: detection, mechanism and treatment. Int J Antimicrob Agents. 2020. doi:10.1016/j.ijantimicag.2020.105950.
   Web of Science ®Google Scholar
• Tseng C-T, Sbrana E, Iwata-Yoshikawa N, Newman PC, Garron T, Atmar RL, Peters CJ, Couch RB. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with SARS virus. PLoS ONE. 2012;7:e35421.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017;8:15092.
   PubMed Web of Science ®Google Scholar
• Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742.
   PubMed Web of Science ®Google Scholar
• Yu F, Du L, Ojcius DM, Pan C, Jiang S. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020;22:74–79.
   PubMed Web of Science ®Google Scholar
• Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc Natl Acad Sci U S A. 2020. doi:10.1073/pnas.2002589117.
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians needs to know. Am J Obstet Gynecol. 2020. doi:10.1016/j,ajog.2020.02.017.
   Web of Science ®Google Scholar
• Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, Xing F, Liu J, Yip CC-Y, Poon RW-S, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23.
   PubMed Web of Science ®Google Scholar
• Khan S, Nabi G, Han G, Siddique R, Lian S, Shi H, Bashir N, Ali A, Adnan Shereen M. Novel coronavirus: how things are in Wuhan. Clin Microbiol Infect. 2020. doi:10.1016/j.cmi.2020.02.005.
   Web of Science ®Google Scholar
• Liu K-C, Xu P, Lv W-F, Qiu X-H, Yao J-L, Gu J-F, Wei W. CT manifestations of coronavirus disease-2019: a retrospective analysis of 73 cases by disease severity. Eur J Radiol. 2020;126:108941.
   PubMed Web of Science ®Google Scholar
• Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020. doi:10.1016/j.jaut.2020.102433.
   PubMed Web of Science ®Google Scholar
• Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: a brief perspective from the front line. J Infect. 2020;80:373–77.
   PubMed Web of Science ®Google Scholar
• Sigrist CJA, Bridge A, Le Mercier P. A potential role for integrins in host cell entry by SARS-CoV-2. Antiviral Res. 2020;177:104759.
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for the virus origins and receptor binding. Lancet. 2020;395:565–74.
   PubMed Web of Science ®Google Scholar
• Luan J, Lu Y, Jin X, Zhang L. Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection. Biochem Biophys Res Commun. 2020. doi:10.1016/j.bbrc.2020.03.047.
   Web of Science ®Google Scholar
• Wall AC, Park Y-J, Tortoici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020. doi:10.1016/j.cell.2020.02.058.
   Google Scholar
• Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, Chen H, Wang D, Liu N, Liu D, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;80:401–06.
   PubMed Web of Science ®Google Scholar
• El-Zowalaty ME, Jarhult JD. From SARS to COVID-19: a previously unknown SARS-related coronavirus (SARS-CoV-2) of pandemic potential infecting humans- Call for a One Health approach. One Health. 2020;9:100124.
   PubMed Web of Science ®Google Scholar
• Jiang X, Deng L, Zhu Y, Ji H, Tao L, Liu L, Yang D, Ji W. Psychological crisis intervention during the outbreak period of new coronavirus pneumonia from experience in Shanghai. Psychiatry Res. 2020;286:112903.
   PubMed Web of Science ®Google Scholar
• Du H-Z, Hou X-Y, Miao Y-H, Huang D-S, Liu D-H. Traditional Chinese medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP). Chin J Nat Med. 2020;18:206–10.
   PubMed Web of Science ®Google Scholar
• Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C, Zeng B, Li Z, Li X, Li H. Diagnosis of the coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol. 2020;126:108961.
   PubMed Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3).
   Google Scholar
• Rello J, Tejada S, Userovici C, Arvaniti K, Pugin J, Waterer G. Coronavirus Disease 2019 (COVID-19): a critical care perspective beyond China. Anaesth Crit Care Pain Med. 2020. doi:10.1016/j.accpm.2020.03.001.
   Web of Science ®Google Scholar
• Rubin EJ, Baden LR, Morrissey S, Campion EW. Campion, Medical Journals and the 2019-nCoV Outbreak. N Engl J Med. 2020.
   Web of Science ®Google Scholar
• Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI-P, Gutierrez RA, Gwee SXW, Chua PEY, Yang Q, et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel coronavirus (2019-nCoV): a systematic review. J Clin Med. 2020;9:623.
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;1–3.
   PubMed Web of Science ®Google Scholar
• Lin Q, Zhao S, Gao D, Lou Y, Yang S, Musa SS, Wang MH, Cai Y, Wang W, Yang L, et al. A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action. Int J Infect Dis. 2020;93:211–16.
   PubMed Web of Science ®Google Scholar
• Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modeling study. Lancet Public Health. 2020. doi:10.1016/S2468-2667(20)30073-6.
   PubMed Web of Science ®Google Scholar
• Sun Z, Thilakavathy K, Kumar SS, He G, Liu SV. Potential factors influencing repated SARS outbreaks in China. Int J Environ Res Public Health. 2020;17:1633.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Jung S-M, Linton NM, Kinoshita R, Hayashi K, Miyama T, Anzai A, Yang Y, Yuan B, Akhmetzhanov AR, et al. Communicating the risk of death from novel coronavirus disease (COVID-19). J Clin Med. 2020;9:580.
   PubMed Web of Science ®Google Scholar
• Grubaugh ND, Petrone ME, Holmes EC. We should not worry when a virus mutates during disease outbreaks. Nat Microbiol. 2020. doi:10.1038/s41564-020-0690-4.
   Web of Science ®Google Scholar
• Zhang Y-Z, Holmes EC. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020. doi:10.1016/j.cell.2020.03.035.
   Web of Science ®Google Scholar
• Zhao S, Ling K, Yan H, Zhong L, Peng X, Yao S, Huang J, Chen X. Anesthetic management of patients with COVID 19, infections during emergency procedures. J Cardiothorac Vasc Anesth. 2020;34:1125–31.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica Chimica Acta. 2020;506:145–48.
   PubMed Web of Science ®Google Scholar
• Lv D-F, Ying Q-M, Weng Y-S, Shen C-B, Chu J-G, Kong J-P, Sun D-H, Gao X, Weng X-B, Chen X-Q. Dynamic change process of target genes by RT-PCR testing of SARS-CoV-2 during the course of a Coronavirus Disease 2019 patient. Clinica Chimica Acta. 2020;506:172–75.
   PubMed Web of Science ®Google Scholar
• Xie C, Jiang L, Huang G, Pu H, Gong B, Lin H, Ma S, Chen X, Long B, Si G, et al. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis. 2020;93:264–67.
   PubMed Web of Science ®Google Scholar
• Guo H, Zhou Y, Liu X, Tan J. The impact of the COVID-19 epidemic on the utilization of emergency dental services. J Dent Sci. 2020. doi:10.1016/j.jds.2020.02.002.
   PubMed Web of Science ®Google Scholar
• Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020.
   Web of Science ®Google Scholar
• Sheahan TP, Sims AC, Graham RL, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9:eaal3653.
   PubMed Web of Science ®Google Scholar
• Wang K, Kang S, Tian R, Zhang X, Zhang X, Wang Y. Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area. Clin Radiol. 2020. doi:10.1016/j.crad.2020.03.004.
   Web of Science ®Google Scholar
• Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020.
   Web of Science ®Google Scholar
• Shen M, Zhou Y, Ye J, Al-maskri AAA, Kang Y, Zeng S, Cai S. Recent advances and perspectives of nucleic acid detection for coronavirus. J Pharm Anal. 2020. doi:10.1016/j.jpha.2020.02.010.
   Web of Science ®Google Scholar
• Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020. doi:10.1080/09273948.2020.1738501.
   PubMed Web of Science ®Google Scholar
• Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, Rubin R, Morales-Estrada S, Black SR, Pacilli M, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020. doi:10.1016/S0140-6736(20)30607-3.
   PubMed Web of Science ®Google Scholar
• Bai L, Yang D, Wang X, Tong L, Zhu X, Zhong N, Bai C, et al. Chinese experts, consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19). Clin eHealth. 2020;3:7–15.
   Google Scholar
• Li L, Yang Z, Dang Z, Meng C, Huang J, Meng H, Wang D, Chen G, Zhang J, Peng H, et al. Propagation analysis and prediction of the COVID-19. Infect Dis Model. 2020;5:282–92.
   PubMedGoogle Scholar
• Skariyachan S, Challapilli SB, Packirisamy S, Kumargowda ST, Sridhar VS. Recent aspects on the pathogenesis mechanism, animal models and novel therapeutic interventions for Middle East respiratory syndrome coronavirus infections. Front Microbiol. 2019;10:569.
   PubMed Web of Science ®Google Scholar
• Zhao J, Li K, Wohlford-Lenane C, et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci USA. 2014;111:4970–75.
   PubMed Web of Science ®Google Scholar
• Agrawal AS, Tao X, Algaissi A, et al. Immunization with inactivated Middle East respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Human Vaccine Immunother. 2016;12:2351–56.
   PubMed Web of Science ®Google Scholar
• Spruth M, et al. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulate neutralizing and protective anibody responses. Vaccine. 2006;24:652–61.
   PubMed Web of Science ®Google Scholar
• Bolles M, et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon. J Virol. 2011;85:12201–15.
   PubMed Web of Science ®Google Scholar
• Hilgenfeld R, Peiris M. From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. Antivir Res. 2013;100:286–95.
   PubMed Web of Science ®Google Scholar
• Zuma A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995–1007.
   PubMed Web of Science ®Google Scholar
• Liu R, Wang J, Shao Y, Wang X, Zhang H, Shuai L, Ge J, Wen Z, Bu Z. A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization. Antiviral Res. 2018;150:30–38.
   PubMed Web of Science ®Google Scholar
• Nyon MP, Du L, Tseng C-TK, Seid CA, Pollet J, Naceanceno KS, Agrawal A, Algaissi A, Peng B-H, Tai W, et al. Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen. Vaccine. 2018;36:1853–62.
   PubMed Web of Science ®Google Scholar
• Ma C, Wang L, Tao X, Zhang N, Yang Y, Tseng C-TK, Li F, Zhou Y, Jiang S, Du L. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments- The importance of immunofocusing in subunit vaccine design. Vaccine. 2014;32:6170–76.
   PubMed Web of Science ®Google Scholar
• Ma C, Li Y, Wang L, Zhao G, Tao X, Tseng C-TK, Zhou Y, Du L, Jiang S. Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication of designing novel mucosal MERS vaccines. Vaccine. 2014;32:2100–08.
   PubMed Web of Science ®Google Scholar
• Wang C, Zheng X, Gai W, Wong G, Wang H, Jin H, Feng N, Zhao Y, Zhang W, Li N, et al. Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice. Antivir Res. 2017;140:55–61.
   PubMed Web of Science ®Google Scholar
• Okada M, Okuno Y, Hashimoto S, Kita T, Kanamaru N, et al. Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. Vaccine. 2007;25:3038–40.
   PubMed Web of Science ®Google Scholar
• Huang J, Ma R, Wu C-Y. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. Vaccine. 2006;24:4905–13.
   PubMed Web of Science ®Google Scholar
• He Y, Zhou Y, Siddiqui P, Jiang S. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochem Biophys Res Commun. 2004;325:445–52.
   PubMed Web of Science ®Google Scholar
• Kuate S, Cinatl J, Doerr HW, Uberla K. Exosomal vaccines containing the S protin of the SARS coronavirus induce high levels of neutralizing antibodies. Virology. 2007;362:26–37.
   PubMed Web of Science ®Google Scholar
• Wang X, Xu W, Tong D, Ni J, Gao H, Wang Y, Chu Y, Li P, Yang X, Xiong S. A chimeric multi-epitope DNA vaccine elicited specific antibody response against sevre acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro. Immunol Lett. 2008;119:71–77.
   PubMed Web of Science ®Google Scholar
• Xiong S, Wang Y-F, Zhang M-Y, Liu X-J, Zhang C-H, Liu -S-S, Qian C-W, Li J-X, Lu J-H, Wan Z-Y, et al. Immunogenicity of SARS inactivated vaccine in BALB/c mice. Immunol Lett. 2004;95:139–43.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Post P, Chubet R, Holtz K, McPherson C, Petric M, Cox M. A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. Vaccine. 2006;24:3624–31.
   PubMed Web of Science ®Google Scholar
• Zakhartchouk AN, Liu Q, Petric M, Babiuk LA. Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. Vaccine. 2005;23:4385–91.
   PubMed Web of Science ®Google Scholar
• Kapadia SU, Simon ID, Rose JK. SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector. Virology. 2008;376:165–72.
   PubMed Web of Science ®Google Scholar
• Herst CV, Burkholz S, Sidney J, Sette A, Harris PE, et al. An effective CTL peptide vaccine for Eolca Zaire based on the survivors, CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design. Vaccine. 2020.
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y. Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmun Rev. 2010;19:102538.
   Google Scholar
• Ji H, Yan Y, Ding B, Guo W, Brunswick M, Niethammer A, SooHoo W, Smith R, Nahama A, Zhang Y. Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressin cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus. Med Drug Discov. 2020;5:100026.
   PubMedGoogle Scholar
• Amanat F, Krammer R. SARS-CoV-2 vaccines: status report. Immunity. 2020;52:583–89.
   PubMed Web of Science ®Google Scholar
• Taylor A, et al. Fc receptors in antibody-dependent enhancement of viral infection. Immunol Rev. 2015;268:340–64.
   PubMed Web of Science ®Google Scholar
• Smatti MK, et al. Viral-induced enhanced disease illness. Front Microb. 2018;9:2991.
   PubMed Web of Science ®Google Scholar
• Wan Y, et al. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol. 2020;94:e02015–19.
   PubMed Web of Science ®Google Scholar
• Qin C, et al. Dysregulation of the immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020.
   Web of Science ®Google Scholar
• Ricke D, Malone R Medical countermeasures analysis of 2019-nCoV and vaccine risks for antibody-dependent enhancement (ADE). 2020.
   Google Scholar
• Quinlan BD, et al. The SARS-CoV-2 receptor-binding elicits a potent neutralizing response without antibody-dependent enhancement. Immunity. 2020.
   Google Scholar
• Zhang B, et al. Immune phenotyping based on neutrophil-to-lymphocyte ration and lgC predicts severity and outcome for patients with COVID-19. medRxiv 2020.
   Google Scholar
• Zhao J, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020.
   Web of Science ®Google Scholar
• Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020.
   PubMed Web of Science ®Google Scholar
• Du L, et al. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine. 2007;25:2832–38.
   PubMed Web of Science ®Google Scholar
• Chen WH, et al. Optimization of the production process and characterization of the yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1), a SARS vaccine candidate. J Pharm Sci. 2017;106:1961–70.
   PubMed Web of Science ®Google Scholar
• Yip MS, et al. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. Hong Kong Med J. 2016;22:25–31.
   PubMedGoogle Scholar
• Wang SF, et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem Biophys Res Commun. 2014;451:208–14.
   PubMed Web of Science ®Google Scholar
• Liu L, et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019;4:e123158.
   PubMed Web of Science ®Google Scholar
• Tan W, et al. Viral kinetics and antibody responses in pateitns with COVID-10. Preprint at medRxiv 10.1101/2020.03.24.20042382 2020.
   Google Scholar
• Jiang H-W, et al. Global profiling of SARS-CoV-2 specific lgG/lgM responses of convalescents using proteome microarray. Preprint at medRxiv 10.1101/2020.03.20.20039495 2020.
   Google Scholar
• Wu F, et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. Preprint at medRxiv Doi:10.1101/2020.03.30.20047365 2020.
   Google Scholar
• Iwasaki A, Yang Y. The potential danger of suboptimal antibody responses in COVID-19. Nature. 2020;20:339–41.
   Web of Science ®Google Scholar
• Wang J, Zand MS. The potential for antibody-dependent enhancement of SARS-CoV-2 infection: translational implications for vaccine development. J Clin Transl Sci. 2020;1–4. doi:10.1017/cts.2020.39.
   PubMedGoogle Scholar